دورية أكاديمية

806P Updated toxicity profile and relapse-free survival outcomes using an adapted pyrexia management algorithm in patients with resected stage III BRAF V600E/K-mutant melanoma treated with adjuvant dabrafenib plus trametinib in COMBI-APlus

التفاصيل البيبلوغرافية
العنوان: 806P Updated toxicity profile and relapse-free survival outcomes using an adapted pyrexia management algorithm in patients with resected stage III BRAF V600E/K-mutant melanoma treated with adjuvant dabrafenib plus trametinib in COMBI-APlus
المؤلفون: Del Vecchio, M., Atkinson, V.G., Ryll, B., Menzies, A.M., Aubin, F., Chiarion Sileni, V., Ferraresi, V., Lesimple, T., Rinaldi, G., Saiag, P., Robert, C., Dutriaux, C., Gogas, H.J., Demidov, L., Gupta, A., Banerjee, H., Sudhir, S., Miranda, F., Lau, M.R., Grob, J.J.
المصدر: In Annals of Oncology September 2022 33 Supplement 7:S914-S914
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2022.07.932